Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5220770
Max Phase: Preclinical
Molecular Formula: C209H343N65O54S
Molecular Weight: 4662.51
Associated Items:
ID: ALA5220770
Max Phase: Preclinical
Molecular Formula: C209H343N65O54S
Molecular Weight: 4662.51
Associated Items:
Canonical SMILES: CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(N)=O)C(C)C)C(C)C)C(C)C)[C@@H](C)O
Standard InChI: InChI=1S/C209H343N65O54S/c1-18-113(12)167(270-161(287)103-237-175(298)152(99-162(288)289)263-199(322)154(104-275)267-173(296)128(218)97-123-101-231-107-238-123)204(327)265-150(92-118-42-20-19-21-43-118)197(320)274-168(117(16)278)205(328)266-153(100-163(290)291)196(319)269-156(106-277)200(323)261-149(96-122-62-70-127(282)71-63-122)194(317)268-155(105-276)198(321)251-139(54-40-87-234-208(227)228)186(309)259-147(94-120-58-66-125(280)67-59-120)192(315)250-138(53-39-86-233-207(225)226)182(305)244-131(46-24-32-79-212)178(301)253-142(73-75-158(220)284)188(311)254-143(76-89-329-17)176(299)240-116(15)172(295)271-164(110(6)7)201(324)255-135(50-28-36-83-216)180(303)245-133(48-26-34-81-214)184(307)260-148(95-121-60-68-126(281)69-61-121)193(316)257-145(91-109(4)5)190(313)241-114(13)170(293)239-115(14)171(294)272-165(111(8)9)203(326)264-144(90-108(2)3)174(297)236-102-160(286)242-130(45-23-31-78-211)177(300)247-137(52-38-85-232-206(223)224)181(304)246-134(49-27-35-82-215)183(306)258-146(93-119-56-64-124(279)65-57-119)191(314)249-132(47-25-33-80-213)179(302)252-141(72-74-157(219)283)187(310)248-140(55-41-88-235-209(229)230)189(312)273-166(112(10)11)202(325)256-136(51-29-37-84-217)185(308)262-151(98-159(221)285)195(318)243-129(169(222)292)44-22-30-77-210/h19-21,42-43,56-71,101,107-117,128-156,164-168,275-282H,18,22-41,44-55,72-100,102-106,210-218H2,1-17H3,(H2,219,283)(H2,220,284)(H2,221,285)(H2,222,292)(H,231,238)(H,236,297)(H,237,298)(H,239,293)(H,240,299)(H,241,313)(H,242,286)(H,243,318)(H,244,305)(H,245,303)(H,246,304)(H,247,300)(H,248,310)(H,249,314)(H,250,315)(H,251,321)(H,252,302)(H,253,301)(H,254,311)(H,255,324)(H,256,325)(H,257,316)(H,258,306)(H,259,309)(H,260,307)(H,261,323)(H,262,308)(H,263,322)(H,264,326)(H,265,327)(H,266,328)(H,267,296)(H,268,317)(H,269,319)(H,270,287)(H,271,295)(H,272,294)(H,273,312)(H,274,320)(H,288,289)(H,290,291)(H4,223,224,232)(H4,225,226,233)(H4,227,228,234)(H4,229,230,235)/t113-,114-,115-,116-,117+,128-,129-,130-,131-,132-,133-,134-,135-,136-,137-,138-,139-,140-,141-,142-,143-,144-,145-,146-,147-,148-,149-,150-,151-,152-,153-,154-,155-,156-,164-,165-,166-,167-,168-/m0/s1
Standard InChI Key: XQYWLRVRAMKFHZ-WYBJURANSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 4662.51 | Molecular Weight (Monoisotopic): 4659.5813 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Hu E, Hong FT, Aral J, Long J, Piper DE, Poppe L, Andrews KL, Hager T, Davis C, Li H, Wong P, Gavva N, Shi L, Zhu DXD, Lehto SG, Xu C, Miranda LP.. (2021) Discovery of Selective Pituitary Adenylate Cyclase 1 Receptor (PAC1R) Antagonist Peptides Potent in a Maxadilan/PACAP38-Induced Increase in Blood Flow Pharmacodynamic Model., 64 (6.0): [PMID:33715378] [10.1021/acs.jmedchem.0c01396] |
Source(1):